Showing results (21-30 of 2,890) with videos related to
Sort By:
Pageof 289
Biochemical Pharmacology|February 1, 1982
Repeated administration of sulpiride for three weeks produces behavioural and biochemical evidence for cerebral dopamine receptor supersensitivityP Jenner, M D Hall, K Murugaiah, et al.Acta Psychiatrica Belgica|September 1, 1987
Neuroleptic-induced tardive dyskinesiaP Jenner, C D MarsdenJournal of Neural Transmission. Supplementum|January 1, 1986
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's diseaseP Jenner, C D MarsdenNeuropharmacology|June 1, 1984
Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to ratsK Murugaiah, S Fleminger, M D Hall, et al.Acta Psychiatrica Scandinavica. Supplementum|January 1, 1984
Multiple dopamine receptors in brain and the pharmacological action of substituted benzamide drugsP Jenner, C D MarsdenEuropean Journal of Pharmacology|November 19, 1981
Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatmentP Jenner, N M Rupniak, M D Hall, et al.Neuroscience Letters|July 3, 1989
Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTPS Rose, M Nomoto, E Kelly, et al.Biochemical Pharmacology|May 15, 1985
SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptorsS Boyce, E Kelly, A Davis, et al.Neuropharmacology|May 1, 1984
Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to ratsM D Hall, D R Cooper, S Fleminger, et al.Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1995
Glutamatergic regulation of striatal peptide gene expression in ratsJ Jolkkonen, P Jenner, C D MarsdenPageof 289